Diseases Associated With Negative Regulation Of Cytokine-Mediated Signaling Pathway
Disease |
Stomach Neoplasms
|
Liver Cirrhosis, Experimental
|
Rheumatoid Arthritis
|
Prostatic Neoplasms
|
Arthritis, Juvenile
|
Asthma
|
Atrial Fibrillation
|
Atrophy
|
Autism
|
Brain Injuries
|
Brain Ischemia
|
Breast Carcinoma
|
Bronchial Hyperreactivity
|
Cardiac Hypertrophy
|
Ulcerative Colitis
|
Colonic Neoplasm
|
Diabetes Mellitus, Experimental
|
Diarrhea
|
Disease Progression
|
Extravasation Of Diagnostic And Therapeutic Materials
|
Fibrosis
|
Open-Angle Glaucoma
|
Gout
|
Hepatitis C
|
Hyperalgesia
|
Hypertension
|
Inflammation
|
Kidney Disease
|
Learning Disorders
|
Leukemia, Myeloid, Acute
|
Lipodystrophy, Congenital Generalized, Type 3
|
Lipodystrophy, Familial Partial
|
Lipoid Proteinosis Of Urbach And Wiethe
|
Liver Failure, Acute
|
Mesothelioma, Malignant
|
Mucositis
|
Multiple Sclerosis
|
Myocardial Infarction
|
Myositis
|
Necrosis
|
Neoplasm Metastasis
|
Ovarian Neoplasms
|
Pain
|
Proteinuria
|
Pulmonary Fibrosis
|
Reperfusion Injury
|
Retinal Diseases
|
Schnitzler Syndrome
|
Sclerosis
|
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, Nk Cell Positive
|
Skin Diseases
|
Status Epilepticus
|
Toxic Epidermal Necrolysis
|
Stroke
|
Abortion, Spontaneous
|
Weight Gain
|
Anorexia
|
Anthracosis
|
Arsenic Poisoning
|